One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro ... Nordisk's GLP-1 agonist Ozempic (semaglutide), a key competitor.

Originally developed for diabetes management ... The “trendification” of Ozempic and semaglutide is putting immense pressure on supply chains and creating a dangerous vacuum – one that's ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

The loss of Gossip Girl start Michelle Tractenberg has put diabetes in the national attention, Tractenberg passed from the blood disease which is a chronic metabolic disorder characterized ...

Novo already sells Rybelsus, an oral semaglutide treatment for diabetes patients, which comes in doses of 7 mg and 14 mg. The company reported sales of 23.3 billion Danish kroner ($3.4 billion ...